Molecular and cellular mechanisms of food allergy and food tolerance.
Chinthrajah, R. S., Hernandez, J. D., Boyd, S. D., Galli, S. J., & Nadeau, K. C. (2016). Molecular and cellular mechanisms of food allergy and food tolerance. Journal of Allergy and Clinical Immunology, 137(4), 984–97.

T-Cell Immunophenotyping of Second-Hand Smoke-related Asthma.
Bauer, R. N., Chinthrajah, R. S., Andorf, S., Hobson, B., Miller, R. L., & Nadeau, K. C. (2016). T-Cell Immunophenotyping of Second-Hand Smoke-related Asthma. Annals of the American Thoracic Society, 13, S95-?

Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis.
Mukai, K., Gaudenzio, N., Gupta, S., Vivanco, N., Bendall, S. C., Maecker, H. T., … Galli, S. J. (2016). Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. Journal of Allergy and Clinical Immunology.

Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis
Mukai, K., Gaudenzio, N., Gupta, S., Vivanco, N., Bendall, S. C., Maecker, H. T., … Galli, S. J. (2017). Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 139(3), 889-?

Omalizumab facilitates rapid oral desensitization for peanut allergy
MacGinnitie, A. J., Rachid, R., Gragg, H., Little, S. V., Lakin, P., Cianferoni, A., … Schneider, L. C. (2017). Omalizumab facilitates rapid oral desensitization for peanut allergy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 139(3), 873-?

Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children.
Andorf, S., Borres, M. P., Block, W., Tupa, D., Bollyky, J. B., Sampath, V., … Nadeau, K. C. (2017). Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children. Journal of Allergy and Clinical Immunology. In Practice.

Isotype-specific agglutination-PCR (ISAP): Asensitive and multiplex method for measuring allergen-specific IgE.
Tsai, C.-T., Mukai, K., Robinson, P. V., Gray, M. A., Waschmann, M. B., Lyu, S.-C., … Galli, S. J. (2018). Isotype-specific agglutination-PCR (ISAP): Asensitive and multiplex method for measuring allergen-specific IgE. The Journal of Allergy and Clinical Immunology, 141(5), 1901.

High dimensional immune biomarkers demonstrate differences in phenotypes and endotypes in food allergy and asthma.
Chinthrajah, R. S., Purington, N., Sampath, V., Andorf, S., Manohar, M., Prunicki, M., … Nadeau, K. C. (2018). High dimensional immune biomarkers demonstrate differences in phenotypes and endotypes in food allergy and asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology.

Development of a tool predicting severity of allergic reaction during peanut challenge.
Chinthrajah, R. S., Purington, N., Andorf, S., Rosa, J. S., Mukai, K., Hamilton, R., … Nadeau, K. C. (2018). Development of a tool predicting severity of allergic reaction during peanut challenge. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology.

Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial
Andorf, S., Purington, N., Block, W. M., Long, A. J., Tupa, D., Brittain, E., … Chinthrajah, R. S. (2018). Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3(2), 85–94.

Epigenetic Changes in Immune Cells Following Successful Desensitization with Multi-Food Allergen Oral Immunotherapy
Chinthrajah, S., Andorf, S., Manohar, M., Maecker, H., Tsai, M., Galli, S., & Nadeau, K. (2018). Epigenetic Changes in Immune Cells Following Successful Desensitization with Multi-Food Allergen Oral Immunotherapy. JOURNAL OF CLINICAL IMMUNOLOGY, 38(3), 358–59.

Changes in Binding Patterns of Cashew-Specific IgE and IgG4 Over the Course of Oral Immunotherapy with Omalizumab
Stankey, C. T., Andorf, S., Tetteh, A., Chinthrajah, S., & Nadeau, K. C. (2018). Changes in Binding Patterns of Cashew-Specific IgE and IgG4 Over the Course of Oral Immunotherapy with Omalizumab. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 141(2), AB246.

Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired
Pellerin, L., Jenks, J. A., Chinthrajah, S., Dominguez, T., Block, W., Zhou, X., … Bacchetta, R. (2018). Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 141(1), 202-+.

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab
Andorf, S., Manohar, M., Dominguez, T., Block, W., Tupa, D., Kshirsagar, R. A., … Nadeau, K. C. (2017). Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 13, 51.

A new fluorescent-avidin-based method for quantifying basophil activation in whole blood
Mukai, K., Chinthrajah, R. S., Nadeau, K. C., Tsai, M., Gaudenzio, N., & Galli, S. J. (2017). A new fluorescent-avidin-based method for quantifying basophil activation in whole blood. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 140(4), 1202-+.

Feasibility of sustained response through long-term dosing in food allergy immunotherapy
Andorf, S., Manohar, M., Dominguez, T., Block, W., Tupa, D., Kshirsagar, R. A., … Nadeau, K. C. (2017). Feasibility of sustained response through long-term dosing in food allergy immunotherapy. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 13, 52.

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Fleischer, D. M., Greenhawt, M., Sussman, G., Begin, P., Nowak-Wegrzyn, A., Petroni, D., … Shreffler, W. (2019). Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA.

Legends of Allergy: Stephen J. Galli.
Tsai, M., Chinthrajah, S., & Nadeau, K. C. (2019). Legends of Allergy: Stephen J. Galli. Allergy.

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.
Wright, B. L., Fernandez-Becker, N. Q., Kambham, N., Purington, N., Tupa, D., Zhang, W., … Chinthrajah, R. S. (2018). Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy. Frontiers in Immunology, 9, 2624.

Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens.
Sindher, S., Long, A. J., Purington, N., Chollet, M., Slatkin, S., Andorf, S., … Chinthrajah, R. S. (2018). Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens. Frontiers in Immunology, 9, 2689.

Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges.
Purington, N., Chinthrajah, R. S., Long, A., Sindher, S., Andorf, S., O'Laughlin, K., … Nadeau, K. C. (2018). Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges. Frontiers in Immunology, 9, 2057.

Heterogeneity of Ara h Component-Specific CD4 T Cell Responses in Peanut-Allergic Subjects.
Renand, A., Farrington, M., Whalen, E., Wambre, E., Bajzik, V., Chinthrajah, S., … Kwok, W. W. (2018). Heterogeneity of Ara h Component-Specific CD4 T Cell Responses in Peanut-Allergic Subjects. Frontiers in Immunology, 9, 1408.

A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.
Andorf, S., Purington, N., Kumar, D., Long, A., O'Laughlin, K. L., Sicherer, S., … Nadeau, K. (2019). A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals. EClinicalMedicine, 7, 27–38.

Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE
Tsai, C.-ting, Mukai, K., Robinson, P. V., Gray, M. A., Waschmann, M. B., Lyu, S.-C., … Galli, S. J. (2018). Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 141(5), 1901-+.

ICER report for peanut OIT comes up short.
Eiwegger, T., Anagnostou, K., Arasi, S., Bégin, P., Ben-Shoshan, M., Beyer, K., … Nadeau, K. (2019). ICER report for peanut OIT comes up short. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology.

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah, R. S., Purington, N., Andorf, S., Long, A., O'Laughlin, K. L., Lyu, S. C., … Nadeau, K. C. (2019). Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet (London, England).

Conflicting verdicts on peanut OIT from the ICER and FDA Advisory Committee; where do we go from here?
Eiwegger, T., Anagnostou, K., Arasi, S., Begin, P., Ben-Shoshan, M., Beyer, K., … Nadeau, K. (2019). Conflicting verdicts on peanut OIT from the ICER and FDA Advisory Committee; where do we go from here? The Journal of Allergy and Clinical Immunology.

Trends in egg specific immunoglobulin levels during natural tolerance and oral immunotherapy.
Andorf, S., Bunning, B., Tupa, D., Cao, S., Long, A. J., Borres, M. P., … Nadeau, K. C. (2019). Trends in egg specific immunoglobulin levels during natural tolerance and oral immunotherapy. Allergy.

Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.
Chinthrajah, S., Cao, S., Liu, C., Lyu, S.-C., Sindher, S. B., Long, A., … Nadeau, K. C. (2019). Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy. JCI Insight, 4(22).

Sustained Successful Peanut Oral Immunotherapy Associated with Low Basophil Activation and Peanut-Specific IgE.
Tsai, M., Mukai, K., Chinthrajah, R. S., Nadeau, K. C., & Galli, S. J. (2019). Sustained Successful Peanut Oral Immunotherapy Associated with Low Basophil Activation and Peanut-Specific IgE. The Journal of Allergy and Clinical Immunology.

Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multifood oral immunotherapy.
Luce, S., Chinthrajah, S., Lyu, S. C., Nadeau, K., & Mascarell, L. (2020). Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multifood oral immunotherapy. Allergy.

Legends of Allergy: Stephen J. Galli
Tsai, M., Chinthrajah, S., & Nadeau, K. C. (2020). Legends of Allergy: Stephen J. Galli. ALLERGY, 75(1), 243–45.

New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy.
Long, A., Borro, M., Sampath, V., & Chinthrajah, R. S. (2020). New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy. Current Allergy and Asthma Reports, 20(1), 3.

Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy.
Hoh, R. A., Joshi, S. A., Lee, J.-Y. Y., Martin, B. A., Varma, S., Kwok, S., … Boyd, S. D. (2020). Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy. Science Immunology, 5(45).

RNA-Seq of Gastrointestinal Biopsies During Oral Immunotherapy Reveals Changes in IgA Pathway
Zhang, W., Dhondalay, G., Hoh, R., Tupa, D., Bunning, B., Fernandez-Becker, N., … Nadeau, K. (2020). RNA-Seq of Gastrointestinal Biopsies During Oral Immunotherapy Reveals Changes in IgA Pathway. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Peanut oral immunotherapy induces gastrointestinal eosinophilia in a longitudinal randomized controlled trial
Wright, B., Fernandez-Becker, N., Kambham, N., Purington, N., Cao, S., Tupa, D., … Chinthrajah, S. (2020). Peanut oral immunotherapy induces gastrointestinal eosinophilia in a longitudinal randomized controlled trial. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Dose-related Allergic Reactions Decrease Over Time During Peanut Oral Immunotherapy in a Large, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
Long, A., Purington, N., Andorf, S., O'Laughlin, K., Lyu, S.-C., Sindher, S., … Nadeau, K. (2020). Dose-related Allergic Reactions Decrease Over Time During Peanut Oral Immunotherapy in a Large, Randomized, Double-blind, Placebo-controlled, Phase 2 Study. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
Chinthrajah, S., Purington, N., Andorf, S., Long, A., O'Laughlin, K., Lyu, S.-C., … Nadeau, K. (2020). Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Protein Composition Changes in Manufactured Penaeus aztecus Shrimp Powder
Chinthrajah, S., Johansson, J., Woch, M., Conn, T., Chen, E., Long, A., … Nadeau, K. (2020). Protein Composition Changes in Manufactured Penaeus aztecus Shrimp Powder. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 145(2), AB226.

Perceived Burden of Treatment and Quality of Life in Long-Term Follow Up after Oral Immunotherapy in Food Allergic Patients
Collins, W., Raeber, O., Tupa, D., Cao, S., Nadeau, K., Sindher, S., & Chinthrajah, S. (2020). Perceived Burden of Treatment and Quality of Life in Long-Term Follow Up after Oral Immunotherapy in Food Allergic Patients. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 145(2), AB147.

Skin TEWL results show significant improvements with Trilipid emollient compared to controls in infants and young children
Nadeau, K., Sindher, S., Berdyshev, E., Shojinaga, M., Alkotob, S., Alonzi, S., … Leung, D. (2020). Skin TEWL results show significant improvements with Trilipid emollient compared to controls in infants and young children. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

The benefits of playing interactive games on virtual reality headsets during procedures in food allergy clinical trials
Alonzi, S., Parikh, K., Varadharajulu, S., Chandra, S., Cao, S., Texeira, Z., … Chinthrajah, S. (2020). The benefits of playing interactive games on virtual reality headsets during procedures in food allergy clinical trials. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 145(2), AB147.

Quality Of Life in Patients with Food Allergy: A Systematic Review and Meta-Analysis of interventions Food Allergy Diagnosis and Immunotherapy Studies
Cao, S., Borro, M., Sindher, S., Tupa, D., Long, A., Chinthrajah, S., … Alonzi, S. (2020). Quality Of Life in Patients with Food Allergy: A Systematic Review and Meta-Analysis of interventions Food Allergy Diagnosis and Immunotherapy Studies. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 145(2), AB245.

A Phase 2 Study of Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Immune Markers after Minimum Maintenance Dose using Xolair
Sindher, S., Kumar, D., Purington, N., Tupa, D., Long, A., Cao, S., … Nadeau, K. (2020). A Phase 2 Study of Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Immune Markers after Minimum Maintenance Dose using Xolair. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 145(2), AB135.

Identification of cross-reactive allergens in cashew- and pistachio-allergic children during oral immunotherapy.
He, Z., Dongre, P., Lyu, S.-C., Manohar, M., Chinthrajah, R. S., Galli, S. J., … Andorf, S. (2020). Identification of cross-reactive allergens in cashew- and pistachio-allergic children during oral immunotherapy. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology.

A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples.
Goyard, S., Balbino, B., Chinthrajah, R. S., Lyu, S.-C. C., Janin, Y. L., Bruhns, P., … Rose, T. (2020). A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples. Allergy.

Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.
Wright, B. L., Fernandez-Becker, N. Q., Kambham, N., Purington, N., Cao, S., Tupa, D., … Chinthrajah, R. S. (2020). Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Consensus Report from the Food Allergy Research and Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit.
Pepper, A. N., Assa'ad, A., Blaiss, M., Brown, E., Chinthrajah, S., Ciaccio, C., … Casale, T. B. (2020). Consensus Report from the Food Allergy Research and Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit. The Journal of Allergy and Clinical Immunology.

ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020).
Bousquet, J., Jutel, M., Akdis, C. A., Klimek, L., Pfaar, O., Nadeau, K. C., … Agache, I. (2020). ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020). Allergy.

Long-Term, Open-Label Extension Study of the Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Children: PEOPLE 3-Year Results.
Fleischer, D. M., Shreffler, W. G., Campbell, D. E., Green, T. D., Anvari, S., Assa'ad, A., … Sampson, H. A. (2020). Long-Term, Open-Label Extension Study of the Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Children: PEOPLE 3-Year Results. The Journal of Allergy and Clinical Immunology.

Increased diversity of gut microbiota during active oral immunotherapy in peanut allergic adults.
He, Z., Vadali, V. G., Szabady, R. L., Zhang, W., Norman, J. M., Roberts, B., … Nadeau, K. C. (2020). Increased diversity of gut microbiota during active oral immunotherapy in peanut allergic adults. Allergy.

Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy.
Wang, W., Lyu, S.-C., Ji, X., Gupta, S., Manohar, M., Dhondalay, G. K., … Maecker, H. T. (2020). Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy. Clinical Immunology (Orlando, Fla.), 108568.

An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.
Fleischer, D. M., Chinthrajah, S., Scurlock, A. M., Campbell, D. E., Green, T. D., Bee, K. J., … Sampson, H. A. (2020). An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial. Allergy and Asthma Proceedings, 41(5), 326–35.

Editorial: Insights Into the Etiology, Prevention, and Treatment of Food Allergy.
Oyoshi, M., & Chinthrajah, R. S. (2020). Editorial: Insights Into the Etiology, Prevention, and Treatment of Food Allergy. Frontiers in Immunology, 11, 1937.

Oral immunotherapy for peanut allergy: The pro argument.
Chinthrajah, R. S., Cao, S., Dunham, T., Sampath, V., Chandra, S., Chen, M., … Nadeau, K. (2020). Oral immunotherapy for peanut allergy: The pro argument. The World Allergy Organization Journal, 13(8), 100455.

Identification of Pru du 6 as a potential marker allergen for almond allergy.
Kabasser, S., Hafner, C., Chinthrajah, S., Sindher, S. B., Kumar, D., Kost, L. E., … Bublin, M. (2020). Identification of Pru du 6 as a potential marker allergen for almond allergy. Allergy.

Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
Fleischer, D. M., Shreffler, W. G., Campbell, D. E., Green, T. D., Anvari, S., Assa'ad, A., … Sampson, H. A. (2020). Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 146(4), 863–74.

Omalizumab in "non-IgE mediated" diseases.
Chinthrajah, R. S., & Galli, S. J. (2020). Omalizumab in "non-IgE mediated" diseases. The Journal of Allergy and Clinical Immunology.

Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes.
Warren, C. M., Turner, P. J., Chinthrajah, R. S., & Gupta, R. S. (2020). Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes. The Journal of Allergy and Clinical Immunology. In Practice.

Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy Study.
Duan, L., Celik, A., Hoang, J. A., Schmidthaler, K., So, D., Yin, X., … Eiwegger, T. (2020). Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut Allergy Study. Allergy.

Corrigendum: Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens.
Sindher, S., Long, A. J., Purington, N., Chollet, M., Slatkin, S., Andorf, S., … Chinthrajah, R. S. (2020). Corrigendum: Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens. Frontiers in Immunology, 11, 625796.

Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy.
Paranjape, A., Tsai, M., Mukai, K., Hoh, R. A., Joshi, S. A., Chinthrajah, R. S., … Galli, S. J. (2020). Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy. Frontiers in Immunology, 11, 602660.

Using data from food challenges to inform management of food-allergic consumers: a systematic review with individual participant data meta-analysis.
Patel, N., Adelman, D. C., Anagnostou, K., Baumert, J. L., Blom, W. M., Campbell, D. E., … Turner, P. J. (2021). Using data from food challenges to inform management of food-allergic consumers: a systematic review with individual participant data meta-analysis. The Journal of Allergy and Clinical Immunology.

SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship.
Skevaki, C., Karsonova, A., Karaulov, A., Fomina, D., Xie, M., Chinthrajah, S., … Renz, H. (2021). SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nature Reviews. Immunology.

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.
Pfaar, O., Klimek, L., Jutel, M., Akdis, C. A., Bousquet, J., Breiteneder, H., … Agache, I. (2021). COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy, 76(3), 648–76.

Bayesian Hierarchical Evaluation of Dose-Response for Peanut Allergy in Clinical Trial Screening.
Haber, L. T., Reichard, J. F., Henning, A. K., Dawson, P., Chinthrajah, R. S., Sindher, S. B., … Allen, B. C. (2021). Bayesian Hierarchical Evaluation of Dose-Response for Peanut Allergy in Clinical Trial Screening. Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association, 112125.

Transcriptomics Of Gastrointestinal Biopsies During Oral Immunotherapy Reveals Changes In IgA Pathway
Dhondalay, G. K., Zhang, W., Hoh, R., Kambham, N., Boyd, S., Andorf, S., … Nadeau, K. (2021). Transcriptomics Of Gastrointestinal Biopsies During Oral Immunotherapy Reveals Changes In IgA Pathway. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Basophil activation tests identify a peanut OIT subgroup with improved safety and outcomes
Chinthrajah, S., Cao, S., Tsai, M., Mukai, K., Tibshirani, R., Sindher, S., … Galli, S. (2021). Basophil activation tests identify a peanut OIT subgroup with improved safety and outcomes. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Mass Cytometry Reveals Immune Signatures Associated With Desensitization Through Multi-Food Oral Immunotherapy.
He, Z., Dunham, D., Zhou, X., Lyu, S.-C., Manohar, M., Chinthrajah, S., … Nadeau, K. (2021). Mass Cytometry Reveals Immune Signatures Associated With Desensitization Through Multi-Food Oral Immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 147(2), AB108.

Outcome of Double-Blind Placebo-Controlled Food Challenges in Shrimp-Sensitized Participants
Jiang, S., Kumar, D., Cao, S., Fitzpatrick, J., Long, A., Woch, M., … Sindher, S. (2021). Outcome of Double-Blind Placebo-Controlled Food Challenges in Shrimp-Sensitized Participants. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Understanding the impact of the COVID-19 pandemic on physical and mental health
Cao, S., Din, H., Warren, C., Fitzpatrick, J., Hernandez-Boussard, T., Desai, M., … Nadeau, K. (2021). Understanding the impact of the COVID-19 pandemic on physical and mental health. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 147(2), AB115.

A positive perception of treatment and continued adherence to dosing in a long-term follow-up study in food allergic participants undergoing multi-food oral immunotherapy
Sindher, S., Kumar, D., Fitzpatrick, J., Cao, S., Long, A., Woch, M., … Chinthrajah, S. (2021). A positive perception of treatment and continued adherence to dosing in a long-term follow-up study in food allergic participants undergoing multi-food oral immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Immune Changes Beyond Th2 Pathways During Rapid Multifood Immunotherapy enabled with Omalizumab.
Manohar, M., Dunham, D., Gupta, S., Yan, Z., Zhang, W., Minnicozzi, S., … Nadeau, K. C. (2021). Immune Changes Beyond Th2 Pathways During Rapid Multifood Immunotherapy enabled with Omalizumab. Allergy.

Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives.
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., … Nadeau, K. C. (2021). Vaccines and Allergic reactions: the past, the current COVID-19 pandemic, and future perspectives. Allergy.

H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
Borro, M., Negrini, S., Long, A., Chinthrajah, S., & Murdaca, G. (2021). H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far? Clinical and Molecular Allergy : CMA, 19(1), 4.

Novel application of a discrete time-to-event model for randomized oral immunotherapy clinical trials with repeat food challenges.
Purington, N., Andorf, S., Bunning, B., Chinthrajah, S., Nadeau, K., & Desai, M. (2021). Novel application of a discrete time-to-event model for randomized oral immunotherapy clinical trials with repeat food challenges. Statistics in Medicine.

Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping.
Suarez-Farinas, M., Suprun, M., Kearney, P., Getts, R., Grishina, G., Hayward, C., … Sampson, H. A. (2021). Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping. Allergy.

Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
Eggert, L. E., He, Z., Collins, W., Lee, A. S., Dhondalay, G., Jiang, S. Y., … Chinthrajah, R. S. (2021). Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19. Allergy.

Improvement in health-related quality of life in food-allergic patients: a meta-analysis.
Cao, S., Borro, M., Alonzi, S., Sindher, S., Nadeau, K., & Chinthrajah, R. S. (2021). Improvement in health-related quality of life in food-allergic patients: a meta-analysis. The Journal of Allergy and Clinical Immunology. In Practice.

Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
Arunachalam, P. S., Scott, M. K., Hagan, T., Li, C., Feng, Y., Wimmers, F., … Pulendran, B. (2021). Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature.

Peanut can be used as a reference allergen for hazard characterization in food allergen risk management: A rapid evidence assessment and meta-analysis.
Turner, P. J., Patel, N., Ballmer-Weber, B. K., Baumert, J. L., Blom, W. M., Brooke-Taylor, S., … Remington, B. C. (2021). Peanut can be used as a reference allergen for hazard characterization in food allergen risk management: A rapid evidence assessment and meta-analysis. The Journal of Allergy and Clinical Immunology. In Practice.

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C. A., Jutel, M., Bachert, C., Klimek, L., Agache, I., … Pawankar, R. (2020). Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. ALLERGY, 75(10), 2440–2444.

New-onset IgG autoantibodies in hospitalized patients with COVID-19.
Chang, S. E., Feng, A., Meng, W., Apostolidis, S. A., Mack, E., Artandi, M., … Utz, P. J. (2021). New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nature Communications, 12(1), 5417.

Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., … Nadeau, K. C. (2021). Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Network Open, 4(9), e2125524.

Shrimp-Allergic Patients in a Multi-Food Oral Immunotherapy Trial.
Nguyen, D.-T. I., Sindher, S. B., Chinthrajah, R. S., Nadeau, K., & Davis, C. M. (2021). Shrimp-Allergic Patients in a Multi-Food Oral Immunotherapy Trial. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology.

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
Dashdorj, N. J., Wirz, O. F., Roltgen, K., Haraguchi, E., Buzzanco, A. S., Sibai, M., … Dashdorj, N. D. (2021). Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. Cell Host & Microbe.

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Pongracic, J. A., Gagnon, R., Sussman, G., Siri, D., Oriel, R. C., Brown-Whitehorn, T., … Begin, P. (2021). Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results. The Journal of Allergy and Clinical Immunology. In Practice.

Food allergy across the globe.
Sampath, V., Abrams, E. M., Adlou, B., Akdis, C., Akdis, M., Brough, H. A., … Renz, H. (2021). Food allergy across the globe. The Journal of Allergy and Clinical Immunology, 148(6), 1347–1364.

Oral Immunotherapy in Children: Clinical Considerations and Practical Management.
Anderson, B., Wong, L., Adlou, B., Long, A., & Chinthrajah, R. S. (2021). Oral Immunotherapy in Children: Clinical Considerations and Practical Management. Journal of Asthma and Allergy, 14, 1497–1510.

A phase 2, randomized multi oral immunotherapy with Omalizumab 'real life' study.
Sindher, S. B., Kumar, D., Cao, S., Purington, N., Long, A., Sampath, V., … Chinthrajah, R. S. (2022). A phase 2, randomized multi oral immunotherapy with Omalizumab 'real life' study. Allergy.

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
Chinthrajah, R. S., Jones, S. M., Kim, E. H., Sicherer, S. H., Shreffler, W., Lanser, B. J., … Wood, R. A. (2022). Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. The Journal of Allergy and Clinical Immunology.

Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Jones, S. M., Kim, E. H., Nadeau, K. C., Nowak-Wegrzyn, A., Wood, R. A., Sampson, H. A., … Burks, A. W. (1800). Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet (London, England), 399(10322), 359–371.

Climate Change and Global Health: A Call to more Research and more Action.
Agache, I., Sampath, V., Aguilera, J., Akdis, C., Akdis, M., Barry, M., … Nadeau, K. C. (1800). Climate Change and Global Health: A Call to more Research and more Action. Allergy.

Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
Jones, S. M., Kim, E. H., Nadeau, K. C., Nowak-Wegrzyn, A., Wood, R. A., Sampson, H. A., … Burks, A. W. (2022). Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. LANCET, 399(10322), 359–371.

Gastrointestinal ?d T cells reveal differentially expressed transcripts and enriched pathways during peanut oral immunotherapy.
Zhang, W., Krishna Dhondalay, G., Liu, T. A., Kaushik, A., Hoh, R., Kwok, S., … Chinthrajah, R. S. (2022). Gastrointestinal ?d T cells reveal differentially expressed transcripts and enriched pathways during peanut oral immunotherapy. Allergy.

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.
Röltgen, K., Nielsen, S. C., Silva, O., Younes, S. F., Zaslavsky, M., Costales, C., … Boyd, S. D. (2022). Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell.

Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study.
Quake, A. Z., Liu, T. A., D'Souza, R., Jackson, K. G., Woch, M., Tetteh, A., … Cao, S. (2022). Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study. Nutrients, 14(4).

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19
Chang, S., Feng, A., Meng, W., Apostolidis, S., Mack, E., Artandi, M., … Utz, P. (2021). New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. ARTHRITIS & RHEUMATOLOGY. WILEY.

Durability of immune responses to the BNT162b2 mRNA vaccine
Suthar, M. S., Arunachalam, P. S., Hu, M., Reis, N., Trisal, M., Raeber, O., … Pulendran, B. (2022). Durability of immune responses to the BNT162b2 mRNA vaccine. MED, 3(1), 25–27.

Providing a safe nest for improved healthcare outcomes in pregnant women with asthma.
Sindher, S. B., Fast, K., Nadeau, K. C., & Chinthrajah, R. S. (2022). Providing a safe nest for improved healthcare outcomes in pregnant women with asthma. The Journal of Allergy and Clinical Immunology. In Practice.

Virtual Reality Reduces Pediatric Anxiety During Food Allergy Clinical Trials: A Pilot Randomized, Pragmatic Study.
Alonzi, S., Caruso, T. J., Sindher, S. B., Cao, S., Varadharajulu, S., Collins, W. J., & Chinthrajah, R. S. (2021). Virtual Reality Reduces Pediatric Anxiety During Food Allergy Clinical Trials: A Pilot Randomized, Pragmatic Study. Frontiers in Allergy, 2, 779804.

Dose-related allergic adverse events during multi-food oral immunotherapy
Gajare, P., Cao, S., Anderson, B., Lloret, M. G., Zedeck, S. S., Kost, L., … Long, A. (2022). Dose-related allergic adverse events during multi-food oral immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Using Nevisense Go to Identify Skin Epithelial Barrier Defect
Lewis, S. N., Adlou, B., Kost, L., Nadeau, K., Chinthrajah, S., Long, A., … Sindher, S. (2022). Using Nevisense Go to Identify Skin Epithelial Barrier Defect. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

SARS-CoV-2 and Perceived Physical, Mental and Social Health in Northern California
Fast, K., Lee, A., Hampton, Q., Chinthrajah, S., Sindher, S., Jia, X., … Cao, S. (2022). SARS-CoV-2 and Perceived Physical, Mental and Social Health in Northern California. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Self-reported food allergy-associated anxiety during oral immunotherapy declines with time
Jiang, S., Cao, S., Collins, W., Fast, K., Hampton, Q., Landes, G., … Chinthrajah, S. (2022). Self-reported food allergy-associated anxiety during oral immunotherapy declines with time. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy
Chinthrajah, S., Jones, S., Kim, E., Sicherer, S., Shreffler, W., Lanser, B., … Wood, R. (2022). Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Addressing Food Insecurity and Improving Food Allergy Management among Pediatric Patient/Caregiver Dyads During the COVID Pandemic
Albarran, M., Warren, C., Chinthrajah, S., Martinez, E., Casareno, L., Rodriguez, A., … Kost, L. (2022). Addressing Food Insecurity and Improving Food Allergy Management among Pediatric Patient/Caregiver Dyads During the COVID Pandemic. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Feasibility of Virtual Reality Technology to Improve Experience During Pediatric Oral Food Challenge
Collins, W., Adlou, B., Rodriguez, A., Albarran, M., O'Neal, E., Weiss, T., … Chinthrajah, S. (2022). Feasibility of Virtual Reality Technology to Improve Experience During Pediatric Oral Food Challenge. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Updated threshold dose-distribution data for sesame.
Turner, P. J., Gretzinger, M., Patel, N., Brough, H., Chinthrajah, R. S., Ebisawa, M., … Remington, B. C. (2022). Updated threshold dose-distribution data for sesame. Allergy.

Durability of immune responses to the BNT162b2 mRNA vaccine.
Suthar, M. S., Arunachalam, P. S., Hu, M., Reis, N., Trisal, M., Raeber, O., … Pulendran, B. (2022). Durability of immune responses to the BNT162b2 mRNA vaccine. Med (New York, N.Y.), 3(1), 25–27.

Current insights: a systemic review of therapeutic options for peanut allergy.
O'Rourke, E., Tang, H., Chin, A., Long, A., Sindher, S., & Chinthrajah, R. S. (2022). Current insights: a systemic review of therapeutic options for peanut allergy. Current Opinion in Allergy and Clinical Immunology, 22(3), 188–193.

Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi-targeted approach.
Sindher, S. B., Long, A., Chin, A. R., Hy, A., Sampath, V., Nadeau, K. C., & Chinthrajah, R. S. (2022). Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi-targeted approach. Allergy.

Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome.
Jia, X., Cao, S., Lee, A. S., Manohar, M., Sindher, S. B., Ahuja, N., … Nadeau, K. C. (2022). Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome. JCI Insight, 7(13).

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
Feyaerts, D., Hédou, J., Gillard, J., Chen, H., Tsai, E. S., Peterson, L. S., … McIlwain, D. R. (2022). Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. Cell Reports. Medicine, 100680.

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
Ozonoff, A., Schaenman, J., Jayavelu, N. D., Milliren, C. E., Calfee, C. S., Cairns, C. B., … Rouphael, N. (2022). Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine, 83, 104208.

The Impact of COVID-19 on a national sample of US Adults with Food Allergy.
Warren, C., Sherr, J., Sindher, S., Nadeau, K. C., Casale, T. B., Ward, D., … Chinthrajah, R. S. (2022). The Impact of COVID-19 on a national sample of US Adults with Food Allergy. The Journal of Allergy and Clinical Immunology. In Practice.

Treatment for Food Allergy: Current Status and Unmet Needs.
Dantzer, J. A., Kim, E. H., Chinthrajah, R. S., & Wood, R. A. (2022). Treatment for Food Allergy: Current Status and Unmet Needs. The Journal of Allergy and Clinical Immunology.

Reply.
Chinthrajah, R. S., Togias, A., & Wood, R. A. (2022). Reply. The Journal of Allergy and Clinical Immunology.

The rationale for development of ligelizumab in food allergy.
Wood, R. A., Chinthrajah, R. S., Eggel, A., Bottoli, I., Gautier, A., Woisetschlaeger, M., … Altman, P. (2022). The rationale for development of ligelizumab in food allergy. The World Allergy Organization Journal, 15(9), 100690.

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
Feyaerts, D., Hédou, J., Gillard, J., Chen, H., Tsai, E. S., Peterson, L. S., … McIlwain, D. R. (2021). Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. BioRxiv : the Preprint Server for Biology.

Systems biological assessment of human immunity to BNT162b2 mRNA vaccination.
Arunachalam, P. S., Scott, M. K., Hagan, T., Li, C., Feng, Y., Wimmers, F., … Pulendran, B. (2021). Systems biological assessment of human immunity to BNT162b2 mRNA vaccination. Research Square.

CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy.
Kaushik, A., Dunham, D., Han, X., Do, E., Andorf, S., Gupta, S., … Nadeau, K. C. (2022). CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy. Nature Communications, 13(1), 6646.

Comorbidity defines risk of asthmatics for COVID-19 hospitalization: a global perspective.
Skevaki, C., Chinthrajah, R. S., Fomina, D., Rohde, G., Cao, S., He, Z., … Renz, H. (2022). Comorbidity defines risk of asthmatics for COVID-19 hospitalization: a global perspective. The Journal of Allergy and Clinical Immunology.

Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens.
Liu, E. G., Zhang, B., Martin, V., Anthonypillai, J., Kraft, M., Grishin, A., … Eisenbarth, S. C. (2022). Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens. Science Translational Medicine, 14(671), eabq0599.

HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success.
Kanchan, K., Shankar, G., Huffaker, M. F., Bahnson, H. T., Chinthrajah, R. S., Sanda, S., … Mathias, R. A. (2022). HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success. Frontiers in Immunology, 13, 941839.

Expression, purification, characterization, and patient IgE reactivity of new macadamia nut iso-allergen.
Zhang, Y., Bhardwaj, S. R., Lyu, S.-C. C., Chinthrajah, S., Nadeau, K. C., & Li, C. (2022). Expression, purification, characterization, and patient IgE reactivity of new macadamia nut iso-allergen. Protein Expression and Purification, 106211.

IgE binding epitope mapping with TL1A tagged peptides.
Zhang, Y., Bhardwaj, S. R., Vilches, A., Breksa, A., Lyu, S.-C., Chinthrajah, S., … Jin, T. (2022). IgE binding epitope mapping with TL1A tagged peptides. Molecular Immunology, 153, 194–199.

Omalizumab in IgE-mediated food allergy: A systematic review and meta-analysis.
Zuberbier, T., Wood, R. A., Bindslev-Jensen, C., Fiocchi, A., Chinthrajah, R. S., Worm, M., … Tassinari, P. (2022). Omalizumab in IgE-mediated food allergy: A systematic review and meta-analysis. The Journal of Allergy and Clinical Immunology. In Practice.

Correction: Quake et al. Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study. Nutrients 2022, 14, 737.
Quake, A. Z., Liu, T. A., D'Souza, R., Jackson, K. G., Woch, M., Tetteh, A., … Cao, S. (2022). Correction: Quake et al. Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study. Nutrients 2022, 14, 737. Nutrients, 15(1).

Transitioning from epicutaneous to oral peanut immunotherapy.
Wong, L., Kost, L., Anderson, B., Long, A., Sindher, S. B., Chinthrajah, R. S., & Collins, W. J. (2023). Transitioning from epicutaneous to oral peanut immunotherapy. Frontiers in Allergy, 4, 1089308.

The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders.
Sindher, S. B., Barshow, S., Tirumalasetty, J., Arasi, S., Atkins, D., Bauer, M., … Chinthrajah, R. S. (2023). The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders. The Journal of Allergy and Clinical Immunology, 151(3), 595–606.

Quantitative analysis of urinary cytokines in food-allergic and healthy individuals.
Lee, A. S., Parsons, E. S., Chang, I., Dunham, D., Chinthrajah, R. S., & Nadeau, K. C. (2023). Quantitative analysis of urinary cytokines in food-allergic and healthy individuals. Allergy.

WAO consensus on DEfinition of Food Allergy SEverity (DEFASE).
Arasi, S., Nurmatov, U., Dunn-Galvin, A., Roberts, G., Turner, P. J., Shinder, S. B., … Fiocchi, A. (2023). WAO consensus on DEfinition of Food Allergy SEverity (DEFASE). The World Allergy Organization Journal, 16(3), 100753.

Advances and potential of omics studies for understanding the development of food allergy.
Sindher, S. B., Chin, A. R., Aghaeepour, N., Prince, L., Maecker, H., Shaw, G. M., … Chinthrajah, R. S. (2023). Advances and potential of omics studies for understanding the development of food allergy. Frontiers in Allergy, 4, 1149008.

Food allergy risks and dining industry - an assessment and a path forward.
Stankovich, G. A., Warren, C. M., Gupta, R., Sindher, S. B., Chinthrajah, R. S., & Nadeau, K. C. (2023). Food allergy risks and dining industry - an assessment and a path forward. Frontiers in Allergy, 4, 1060932.

Treatment of food allergy: oral immunotherapy, biologics and beyond.
Sindher, S. B., Hillier, C., Anderson, B., Long, A., & Chinthrajah, R. S. (2023). Treatment of food allergy: oral immunotherapy, biologics and beyond. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology.

Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial.
Groetch, M., Mudd, K., Woch, M., Schaible, A., Gray, B. E., Babineau, D. C., … Wood, R. (2023). Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial. The Journal of Allergy and Clinical Immunology. In Practice, 11(2), 572–580.e2.

Refractory anaphylaxis: a new entity for severe anaphylaxis.
Pouessel, G., Deschildre, A., Dribin, T. E., Ansotegui, I. J., Cardona, V., Chinthrajah, R. S., … Turner, P. J. (2023). Refractory anaphylaxis: a new entity for severe anaphylaxis. The Journal of Allergy and Clinical Immunology. In Practice.

Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
Arunachalam, P. S., Scott, M. K., Hagan, T., Li, C., Feng, Y., Wimmers, F., … Pulendran, B. (2023). Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature.

Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach.
Greenhawt, M., Dribin, T. E., Abrams, E. M., Shaker, M., Chu, D. K., Golden, D. B., … Yacoub, M.-R. (2023). Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach. The Journal of Allergy and Clinical Immunology.

Efficacy of a 6-Month Online Market Platform in Addressing Food Insecurity and Supporting Food Allergy Management in Predominantly Spanish-speaking and Low-income communities During the COVID-19 Pandemic
Albarran, M., Warren, C., Chinthrajah, S., Green, C., Martinez, E., Brown, E., … Woch, M. (2023). Efficacy of a 6-Month Online Market Platform in Addressing Food Insecurity and Supporting Food Allergy Management in Predominantly Spanish-speaking and Low-income communities During the COVID-19 Pandemic. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

The Effects of Long-term Food Oral Immunotherapy on Compliance, Quality of Life, and Perceived Burden of Care
Tirumalasetty, J., Sullivan, L., Martinez, K., Collins, W., Albarran, M., Gajare, P., … Cao, S. (2023). The Effects of Long-term Food Oral Immunotherapy on Compliance, Quality of Life, and Perceived Burden of Care. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Multiplexed Tissue Imaging for Immune Cells Profiling During Peanut Allergy Immunotherapy
Kaushik, A., Angoshtari, R., Kwow, S., Kambham, N., Fernandez-Becker, N., Manohar, M., … Chinthrajah, S. (2023). Multiplexed Tissue Imaging for Immune Cells Profiling During Peanut Allergy Immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

The Impact of Persistent Gastrointestinal Symptoms on Completion of Oral Immunotherapy in Clinical Trials
Lim, J., Cao, S., Chinthrajah, S., & Sindher, S. (2023). The Impact of Persistent Gastrointestinal Symptoms on Completion of Oral Immunotherapy in Clinical Trials. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Management of Eosinophilic Esophagitis in Pediatric Patients Undergoing Food Allergen Oral Immunotherapy
Jia, X., Chin, A., Khavari, N., Haija, M., McGhee, S., Chinthrajah, S., & Sindher, S. (2023). Management of Eosinophilic Esophagitis in Pediatric Patients Undergoing Food Allergen Oral Immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. MOSBY-ELSEVIER.

Neuroimmune Pathways and Allergic Disease: An Overview.
Long, A., Ferretti-Gallon, J. J., Chin, A. R., Chinthrajah, R. S., & Sindher, S. B. (2023). Neuroimmune Pathways and Allergic Disease: An Overview. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology.

The SunBEAm birth cohort: Protocol design.
Keet, C., Sicherer, S. H., Bunyavanich, S., Visness, C., Fulkerson, P. C., Togias, A., … Wood, R. A. (2023). The SunBEAm birth cohort: Protocol design. The Journal of Allergy and Clinical Immunology. Global, 2(3).

Recent Mechanistic Studies in Allergic Diseases.
Sindher, S. B., Sharma, R., Yarlagadda, M., Chin, A. R., & Chinthrajah, R. S. (2023). Recent Mechanistic Studies in Allergic Diseases. International Journal of Molecular Sciences, 24(18).

Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
Wimmers, F., Burrell, A. R., Feng, Y., Zheng, H., Arunachalam, P. S., Hu, M., … Pulendran, B. (2023). Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth. Cell.

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH).
Wood, R. A., Chinthrajah, R. S., Rudman Spergel, A. K., Babineau, D. C., Sicherer, S. H., Kim, E. H., … Togias, A. (2022). Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH). The Journal of Allergy and Clinical Immunology. Global, 1(4), 225–232.